Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.
Severe scrutiny of two major papers, including one about the effectiveness of hydroxychloroquine, is part of science's normal process of self-correction, explains Mark R. O’Brian.
As COVID-19 shuttered laboratories across the U.S., many researchers were forced to euthanize the animals they study. Lindsay Gray, a rodent surgeon in an animal research lab that faced this dilemma, argues here there is a safer, more effective way.
Early in adulthood, the brain regenerates lost myelin effectively, but remyelination falters with age. Researchers seek to understand why — and what the change may mean for people with multiple sclerosis.
Meet Our Contributors
Science Policy Manager
The Endless Frontier Act would rename, add a directorate to and pump up to $100 billion in new funding into the agency. It also would fix the uneven distribution of jobs and capital concentrated now in just a few cities. Read More
Jerry Hart, the ASBMB’s outgoing president, looks back at two years of big changes and advances at the society and in science. Read More
A metal ion that transforms tau. A new target to take out cancer cells. One substitution that abolishes enzyme allostery. Read about recent papers on these topics and more in the Journal of Biological Chemistry. Read More
Director of Public Affairs
As a result of the Trump administration’s actions and inaction, Ben Corb writes, the U.S. was late to adopt a testing protocol to help track and slow the spread of COVID-19. Read More
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.